PharmaRadar360

PharmaRadar360

🌍·Aug 24discovery

China Resources Pharmaceutical Group: Revenue up 2.0% YoY to RMB134.5B; net profit RMB5.02B; interim dividend up 21%

Publisher

T
TradingView

Global

This page provides publisher metadata, and related coverage to support discovery before sending readers to the original article.

Read original

At a glance

Publisher
TradingView
Region
Global
Scope
discovery
Published
August 24, 2026
Language
EN

Publisher context, original article off-platform

This page presents the title, publisher metadata, and related coverage. The publisher did not provide a public summary in this feed. Full-text reading stays on the publisher's original site.

Source route

Continue on news.google.com

Leave the platform to read the original full article on the publisher site.

Source: TradingView

Scope: discovery

Open original article
China Resources Pharmaceutical Group: Revenue up 2.0% YoY to RMB134.5B; net profit RMB5.02B; interim dividend up 21% | PharmaRadar360